DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0011581 | Depressive disorder | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0013421 | Dystonia | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0684276 | Hypsarrhythmia | MAN1B1 | 11253 | mannosidase alpha class 1B member 1 | Q9UKM7 |
C0007134 | Renal Cell Carcinoma | MAN1C1 | 57134 | mannosidase alpha class 1C member 1 | Q9NR34 |
C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | MAN1C1 | 57134 | mannosidase alpha class 1C member 1 | Q9NR34 |
C0034067 | Pulmonary Emphysema | MAN1C1 | 57134 | mannosidase alpha class 1C member 1 | Q9NR34 |
C0036341 | Schizophrenia | MAN1C1 | 57134 | mannosidase alpha class 1C member 1 | Q9NR34 |
C0027651 | Neoplasms | MAN1C1 | 57134 | mannosidase alpha class 1C member 1 | Q9NR34 |
C0004364 | Autoimmune Diseases | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0024141 | Lupus Erythematosus, Systemic | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C1306459 | Primary malignant neoplasm | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0036341 | Schizophrenia | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C2239176 | Liver carcinoma | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C1621958 | Glioblastoma Multiforme | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0002876 | Congenital dyserythropoietic anemia | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0027651 | Neoplasms | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0600139 | Prostate carcinoma | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0376358 | Malignant neoplasm of prostate | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C1306589 | Congenital dyserythropoietic anemia, type II | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0023452 | Childhood Acute Lymphoblastic Leukemia | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0345904 | Malignant neoplasm of liver | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0006826 | Malignant Neoplasms | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0017636 | Glioblastoma | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | MAN2A1 | 4124 | mannosidase alpha class 2A member 1 | Q16706 |
C1263846 | Attention deficit hyperactivity disorder | MAN2A2 | 4122 | mannosidase alpha class 2A member 2 | P49641 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024